Cancer Gene Therapy Breakthroughs in Ewing's Sarcoma and Osteosarcoma Research

Strategic Insights -

Researchers at the University of Oxford have made significant discoveries in the field of cancer gene therapy, particularly in the regulation and effects of Hypoxia-Inducible Factor (HIF) on Ewing's sarcoma and osteosarcoma. The study, published in Bmc Cancer, sheds light on the expression and function of HIF in primary bone sarcomas. By understanding the role of HIF in cancer development, scientists aim to develop more effective treatments for these aggressive types of bone cancer.

Key Takeaways:

  • HIF expression and function in primary bone sarcomas, particularly Ewing's sarcoma and osteosarcoma, were investigated in the study.
  • Out of 56 Ewing's tumors, 17 were HIF-1alpha-positive, 15 were HIF-2alpha-positive, and 10 were positive for both HIF-1alpha and HIF-2alpha.
  • Hypoxia induced HIF-1alpha and HIF-2alpha in Ewing's and osteosarcoma cell lines, while hypoglycaemia specifically induced HIF-2alpha in Ewing's.
  • Downstream transcription of HIF-1alpha was dependent in Ewing's sarcoma, but regulated by both isoforms in osteosarcoma.
  • Hypoglycaemia reduced cellular proliferation by at least 45%, while hypoxia increased apoptosis in both cell types.
  • HIF siRNA modulated hypoxic proliferation and migration in both Ewing's and osteosarcoma cell lines.
  • Co-localization of HIF-1alpha and necrosis in Ewing's sarcoma suggests a role for hypoxia and/or hypoglycaemia in in vivo induction of HIF.

Statistics:

  • 17 out of 56 Ewing's tumors were HIF-1alpha-positive.
  • 15 out of 56 Ewing's tumors were HIF-2alpha-positive.
  • 10 out of 56 Ewing's tumors were positive for both HIF-1alpha and HIF-2alpha.
  • Hypoglycaemia reduced cellular proliferation by at least 45% in both Ewing's and osteosarcoma cell lines.
  • Hypoxia increased apoptosis in both Ewing's and osteosarcoma cell lines.

Sources:

  • Knowles, H. J., et al. "Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor." Bmc Cancer, 2010;10():372.
  • Bmc Cancer.